Avestar Capital, LLC Laboratory Corp Of America Holdings Transaction History

Avestar Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$159.77 - $178.1 $2,077 - $2,315	-13 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$120.82 - $174.09 $241 - $348	-2 Reduced 13.33%	13 $0
Q3 2018 Oct 23, 2018	SELL	$167.67 - $188.27 $9,557 - $10,731	-57 Reduced 79.17%	15 $2,000
Q2 2018 Aug 10, 2018	BUY	$160.33 - $189.41 $320 - $378	2 Added 2.86%	72 $12,000
Q1 2018 May 10, 2018	BUY	$161.53 - $178.11 $2,422 - $2,671	15 Added 27.27%	70 $9,000
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $8,139 - $9,017	55	55 $7,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.2B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.